"Neoplasm Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm.
| Descriptor ID |
D009363
|
| MeSH Number(s) |
D12.776.624
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Proteins".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Proteins".
This graph shows the total number of publications written about "Neoplasm Proteins" by people in this website by year, and whether "Neoplasm Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 6 | 3 | 9 |
| 1997 | 1 | 3 | 4 |
| 1998 | 3 | 3 | 6 |
| 1999 | 7 | 1 | 8 |
| 2000 | 8 | 6 | 14 |
| 2001 | 6 | 2 | 8 |
| 2002 | 6 | 6 | 12 |
| 2003 | 7 | 6 | 13 |
| 2004 | 11 | 7 | 18 |
| 2005 | 6 | 13 | 19 |
| 2006 | 14 | 4 | 18 |
| 2007 | 11 | 11 | 22 |
| 2008 | 8 | 10 | 18 |
| 2009 | 10 | 6 | 16 |
| 2010 | 5 | 5 | 10 |
| 2011 | 11 | 7 | 18 |
| 2012 | 10 | 6 | 16 |
| 2013 | 10 | 4 | 14 |
| 2014 | 14 | 10 | 24 |
| 2015 | 20 | 8 | 28 |
| 2016 | 8 | 4 | 12 |
| 2017 | 14 | 10 | 24 |
| 2018 | 17 | 6 | 23 |
| 2019 | 16 | 6 | 22 |
| 2020 | 8 | 2 | 10 |
| 2021 | 14 | 7 | 21 |
| 2022 | 1 | 2 | 3 |
| 2023 | 0 | 5 | 5 |
| 2024 | 0 | 4 | 4 |
| 2025 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasm Proteins" by people in Profiles.
-
IL-7 armed binary CAR T cell strategy to augment potency against solid tumors. Front Immunol. 2025; 16:1618404.
-
Clinical impact of pharmacogenetic risk variants in a large chinese cohort. Nat Commun. 2025 Jul 09; 16(1):6344.
-
MAGE-A4 induces non-small cell lung cancer and tumor-promoting plasma cell accumulation. Sci Adv. 2025 Feb 14; 11(7):eads4227.
-
Discovery and prioritization of genetic determinants of kidney function in 297,355 individuals from Taiwan and Japan. Nat Commun. 2024 10 29; 15(1):9317.
-
Distinct landscape and clinical implications of therapy-related clonal hematopoiesis. J Clin Invest. 2024 Oct 01; 134(19).
-
Perturbing TET2 condensation promotes aberrant genome-wide DNA methylation and curtails leukaemia cell growth. Nat Cell Biol. 2024 Dec; 26(12):2154-2167.
-
Hyperkinetic Movement Disorder Caused by the Recurrent c.892C>T NACC1 Variant. Mov Disord Clin Pract. 2024 Jun; 11(6):708-715.
-
EZH2 Cooperates with BRD4-NUT to Drive NUT Carcinoma Growth by Silencing Key Tumor Suppressor Genes. Cancer Res. 2023 12 01; 83(23):3956-3973.
-
The BRD4-NUT Fusion Alone Drives Malignant Transformation of NUT Carcinoma. Cancer Res. 2023 12 01; 83(23):3846-3860.
-
The oncomodulin receptor ArmC10 enables axon regeneration in mice after nerve injury and neurite outgrowth in human iPSC-derived sensory neurons. Sci Transl Med. 2023 08 09; 15(708):eadg6241.